.. Du-choc and .. , p. 29 Effet anti apoptotique des ? bloquants dans le coeur, Impact des ?1 bloquants sur l'hémodynamique, p.31

J. Cohen, The immunopathogenesis of sepsis, Nature, vol.288, issue.6917, pp.885-91, 2002.
DOI : 10.1038/nature01023

D. Angus, The Search for Effective Therapy for Sepsis, JAMA, vol.306, issue.23, pp.2614-2619, 2011.
DOI : 10.1001/jama.2011.1853

J. Berk, J. Hagen, W. Beyer, M. Gerber, and G. Dochat, aent of Endotoxin Shock by Beta Adrenergic Blockade, Annals of Surgery, vol.169, issue.1, pp.74-81, 1969.
DOI : 10.1097/00000658-196901000-00007

M. Levy, M. Fink, and J. Marshall, 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, SIS International Sepsis Definitions Conference, pp.1250-1256, 2001.
DOI : 10.1097/01.CCM.0000050454.01978.3B

G. Martin, D. Mannino, S. Eaton, and M. Moss, The Epidemiology of Sepsis in the United States from 1979 through 2000, New England Journal of Medicine, vol.348, issue.16, pp.1546-54, 2000.
DOI : 10.1056/NEJMoa022139

C. Brun-buisson, P. Meshaka, P. Pinton, and B. Vallet, EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units

M. Pinsky, Pathophysiology of Sepsis and Multiple Organ Failure: Pro- versus Anti-Inflammatory Aspects, Contrib Nephrol, vol.144, pp.31-43, 2004.
DOI : 10.1159/000078875

R. Hotchkiss and I. Karl, The Pathophysiology and Treatment of Sepsis, New England Journal of Medicine, vol.348, issue.2
DOI : 10.1056/NEJMra021333

U. Muller-werdan, M. Buerke, and H. Ebelt, Septic cardiomyopathy -A not yet discovered cardiomyopathy?, Exp Clin Cardiol, vol.11, issue.3, pp.226-262, 2006.

J. Parrillo, Pathogenetic mechanisms of septic shock, N Engl J Med, vol.328, issue.20, pp.1471-1478, 1993.

E. Abraham and M. Singer, Mechanisms of sepsis-induced organ dysfunction, Critical Care Medicine, vol.35, issue.10
DOI : 10.1097/01.CCM.0000282072.56245.91

J. Parrillo, C. Burch, J. Shelhamer, M. Parker, C. Natanson et al., A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance., Journal of Clinical Investigation, vol.76, issue.4, pp.1539-53, 1985.
DOI : 10.1172/JCI112135

W. Shoemaker, P. Appel, and H. Kram, Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure, Critical Care Medicine, vol.16, issue.11, pp.1117-1137, 1988.
DOI : 10.1097/00003246-198811000-00007

D. Meldrum, ??-blockade during sepsis: Inspired or insane?*, Critical Care Medicine, vol.33, issue.10, pp.2433-2437, 2005.
DOI : 10.1097/01.CCM.0000182997.07435.72

R. Nevière, H. Fauvel, C. Chopin, P. Formstecher, and P. Marchetti, Caspase Inhibition Prevents Cardiac Dysfunction and Heart Apoptosis in a Rat Model of Sepsis, American Journal of Respiratory and Critical Care Medicine, vol.160, issue.1
DOI : 10.1073/pnas.96.24.13795

D. Annane, F. Trabold, and T. Sharshar, Inappropriate Sympathetic Activation at Onset of Septic Shock, American Journal of Respiratory and Critical Care Medicine, vol.17, issue.2, pp.458-65, 1999.
DOI : 10.1161/01.CIR.95.6.1449

S. Gibot, B. Lévy, R. Nevière, A. Cariou, and O. Lesur, Dysfonctionnement myocardique et choc septique, m??decine/sciences, vol.20, issue.12, pp.1115-1123, 2004.
DOI : 10.1051/medsci/200420121115

URL : http://www.erudit.org/fr/revues/ms/2004-v20-n12-ms837/009873ar.pdf

M. Parker, J. Shelhamer, and S. Bacharach, Profound but Reversible Myocardial Depression in Patients with Septic Shock, Annals of Internal Medicine, vol.100, issue.4, pp.483-90, 1984.
DOI : 10.7326/0003-4819-100-4-483

A. Hochstadt, Y. Meroz, and G. Landesberg, Myocardial Dysfunction in Severe Sepsis and Septic Shock: More Questions Than Answers?, Journal of Cardiothoracic and Vascular Anesthesia, vol.25, issue.3, pp.526-561, 2011.
DOI : 10.1053/j.jvca.2010.11.026

M. Hayes, E. Yau, A. Timmins, C. Hinds, and D. Watson, Response of Critically III Patients to Treatment Aimed at Achieving Supranormal Oxygen Delivery and Consumption, Chest, vol.103, issue.3, pp.886-95, 1993.
DOI : 10.1378/chest.103.3.886

M. Zaugg, M. Schaub, T. Pasch, and D. Spahn, Modulation of beta-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action

K. Muthu, J. Deng, and F. Romano, Thermal injury and sepsis modulates ??-adrenergic receptors and cAMP reponses in monocyte-committed bone marrow cells, Journal of Neuroimmunology, vol.165, issue.1-2, pp.129-167, 2005.
DOI : 10.1016/j.jneuroim.2005.04.015

W. Hausdorff, M. Caron, and R. Lefkowitz, Turning off the signal: desensitization of beta-adrenergic receptor function., The FASEB Journal, vol.4, issue.11, pp.2881-2890, 1990.
DOI : 10.1096/fasebj.4.11.2165947

H. Silverman, R. Penaranda, J. Orens, and N. Lee, Impaired ??-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock, Critical Care Medicine, vol.21, issue.1, pp.31-40, 1993.
DOI : 10.1097/00003246-199301000-00010

A. Kumar, E. Schupp, E. Bunnell, A. Ali, B. Milcarek et al., Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock, Critical Care, vol.12, issue.2
DOI : 10.1186/cc6814

T. Suzuki, H. Morisaki, and R. Serita, Infusion of the ??-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats*, Critical Care Medicine, vol.33, issue.10, pp.2294-301, 2005.
DOI : 10.1097/01.CCM.0000182796.11329.3B

D. Gore and R. Wolfe, Hemodynamic and metabolic effects of selective ??1 adrenergic blockade during sepsis, Surgery, vol.139, issue.5, pp.686-94, 2006.
DOI : 10.1016/j.surg.2005.10.010

DOI : 10.1097/SHK.0b013e318167378f

D. Rittirsch, M. Huber-lang, M. Flierl, and P. Ward, Immunodesign of experimental sepsis by cecal ligation and puncture, Nature Protocols, vol.22, issue.1, pp.31-37, 2008.
DOI : 10.1164/ajrccm.164.5.2010073

H. Suga, K. Sagawa, and A. Shoukas, Load Independence of the Instantaneous Pressure-Volume Ratio of the Canine Left Ventricle and Effects of Epinephrine and Heart Rate on the Ratio, Circulation Research, vol.32, issue.3, pp.314-336, 1973.
DOI : 10.1161/01.RES.32.3.314

M. Balik, J. Rulisek, and P. Leden, Gleichzeitiger Einsatz von b-1-Rezeptor Blockern und Noradrenalin bei Patienten mit septischem Schock, Wiener klinische Wochenschrift, vol.38, issue.10
DOI : 10.1097/CCM.0b013e3181f204ca

J. Aboab, V. Sebille, and M. Jourdain, Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock, Intensive Care Medicine, vol.371, issue.8, pp.1344-51, 2011.
DOI : 10.1016/S0140-6736(08)60601-7

M. Hayes, A. Timmins, E. Yau, M. Palazzo, C. Hinds et al., Elevation of Systemic Oxygen Delivery in the Treatment of Critically Ill Patients, New England Journal of Medicine, vol.330, issue.24, pp.1717-1739, 1994.
DOI : 10.1056/NEJM199406163302404

J. Robotham, M. Takata, M. Berman, and Y. Harasawa, Ejection Fraction Revisited, Anesthesiology, vol.74, issue.1
DOI : 10.1097/00000542-199101000-00026

A. Vieillard-baron, Septic cardiomyopathy, Annals of Intensive Care, vol.1, issue.1, p.6, 2011.
DOI : 10.1186/cc9207

G. Ackland, S. Yao, and A. Rudiger, Cardioprotection, attenuated systemic inflammation, and survival benefit of ??1-adrenoceptor blockade in severe sepsis in rats*, Critical Care Medicine, vol.38, issue.2, pp.388-94, 2010.
DOI : 10.1097/CCM.0b013e3181c03dfa

T. Gulick, M. Chung, S. Pieper, L. Lange, and G. Schreiner, Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness., Proceedings of the National Academy of Sciences, vol.86, issue.17, pp.6753-6760, 1989.
DOI : 10.1073/pnas.86.17.6753

URL : http://www.pnas.org/content/86/17/6753.full.pdf

A. Kumar, V. Thota, L. Dee, J. Olson, E. Uretz et al., Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum, Journal of Experimental Medicine, vol.183, issue.3, pp.949-58, 1996.
DOI : 10.1084/jem.183.3.949

B. Cain, D. Meldrum, and C. Dinarello, Tumor necrosis factor-alpha and interleukin-1 beta synergistically depress human myocardial function, Critical Care Medicine, vol.27, issue.7, pp.1309-1327, 1999.
DOI : 10.1097/00003246-199907000-00018

C. Gogos, E. Drosou, H. Bassaris, and A. Skoutelis, Pro??? versus Anti???inflammatory Cytokine Profile in Patients with Severe Sepsis: A Marker for Prognosis and Future Therapeutic Options, The Journal of Infectious Diseases, vol.181, issue.1, pp.176-80, 2000.
DOI : 10.1086/315214

R. Levy, D. Piel, and P. Acton, Evidence of myocardial hibernation in the septic heart*, Critical Care Medicine, vol.33, issue.12, pp.2752-2758, 2005.
DOI : 10.1097/01.CCM.0000189943.60945.77

M. Fink, Bench-to-bedside review: Cytopathic hypoxia, Critical Care, vol.6, issue.6, pp.491-500, 2002.
DOI : 10.1186/cc1824

J. Stephens, R. Hayward, H. Ead, L. Adams, J. Hamer et al., Effects of selective and non-selective beta-adrenergic blockade on coronary dynamics in man assessed by rapid atrial pacing., Heart, vol.40, issue.8, pp.856-63, 1978.
DOI : 10.1136/hrt.40.8.856